月経困難症検査の市場規模、シェア、成長分析：製品タイプ別、治療タイプ別、エンドユーザー別、地域別-産業予測、2025～2032年

世界の月経困難症検査の市場規模は2023年に36億米ドルと評価され、2024年の38億9,000万米ドルから2032年には72億6,000万米ドルに成長し、予測期間（2025～2032年）のCAGRは8.1％で成長する見通しです。

世界の月経困難症検査市場は、月経困難症の有病率の増加、月経の健康に対する意識の高まり、診断技術の進歩によって大きな成長を遂げています。月経痛の影響が広範囲に及んでいるため、臨床的評価を求める患者が増加しており、検査サービスの需要を押し上げています。月経困難症検査へのアクセス向上は、月経衛生イニシアチブに資金を提供する政府の支援政策にも起因しています。生殖医療クリニックの増加や不妊治療への関心の高まりは、さらに検査需要の増加に寄与しています。さらに、AIや機械学習などの技術革新は、患者のデータを分析して月経困難症を早期に予測するのに役立つ一方、IoTデバイスは月経中のバイタルサインの継続的なモニタリングを容易にし、最終的に月経困難症の診断と管理の状況を一変させています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次・一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の展望
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 顧客購買行動分析

月経困難症検査市場規模：製品タイプ別& CAGR（2025～2032年）

• 市場概要
• 原発性月経困難症検査
• 続発性月経困難症検査

月経困難症検査市場規模：治療タイプ別& CAGR（2025～2032年）

• 市場概要
• 鎮痛剤
• ホルモン療法
• 手術

月経困難症検査市場規模：エンドユーザー別& CAGR（2025～2032年）

• 市場概要
• 病院・クリニック
• 研究センター

月経困難症検査市場規模：地域別& CAGR（2025～2032年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Pfizer Inc.
• Bayer AG
• Johnson & Johnson Services, Inc.
• Quin
• Abbott Laboratories
• Merck & Co., Inc.
• Global Pharma plc
• Mylan N.V.
• Teva Pharmaceutical Industries Ltd.
• Proteomics Inc.
• Boehringer Ingelheim International GmbH
• Ferring Pharmaceuticals

結論と提言

Global Dysmenorrhea Testing Market size was valued at USD 3.6 billion in 2023 and is poised to grow from USD 3.89 billion in 2024 to USD 7.26 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The global dysmenorrhea testing market is experiencing significant growth, driven by the increasing prevalence of dysmenorrhea, heightened awareness of menstrual health, and advancements in diagnostic technologies. More patients are seeking clinical evaluations due to the widespread impact of menstrual pain, which boosts demand for testing services. Enhanced access to dysmenorrhea testing is also attributed to supportive government policies that fund menstrual health initiatives. The rise in reproductive health clinics and a growing focus on fertility are further contributing to the uptick in testing. Additionally, innovations such as AI and machine learning help analyze patient data to predict dysmenorrhea early, while IoT devices facilitate continual monitoring of vital signs during menstruation, ultimately transforming the landscape of dysmenorrhea diagnosis and management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dysmenorrhea Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dysmenorrhea Testing Market Segments Analysis

Global Dysmenorrhea Testing Market is segmented by Product Type, Type of Treatment, End User and region. Based on Product Type, the market is segmented into Primary Dysmenorrhea Testing and Secondary Dysmenorrhea Testing. Based on Type of Treatment, the market is segmented into Pain Relievers, Hormonal Therapy and Surgery. Based on End User, the market is segmented into Hospitals and Clinics and Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dysmenorrhea Testing Market

The rising prevalence of both primary and secondary dysmenorrhea, coupled with an increased inclination among women to seek healthcare for chronic or severe menstrual pain, is driving the demand for dysmenorrhea testing. As more individuals pursue clarity regarding their conditions, the need for accurate diagnostics becomes essential. Moreover, heightened awareness and advocacy from governmental bodies and non-governmental organizations focused on women's health further promote the importance of medical screenings for menstrual disorders. This growing emphasis on health and well-being ultimately contributes to a burgeoning market for dysmenorrhea testing solutions, reflecting a significant shift towards proactive healthcare management in this area.

Restraints in the Global Dysmenorrhea Testing Market

The Global Dysmenorrhea Testing market faces significant challenges stemming from cultural stigmas surrounding menstruation, which often discourage open discussion and restrict access to necessary menstrual health services. In conservative societies, women frequently experience limitations on their autonomy, which can hinder their ability to pursue healthcare options or prioritize their well-being, particularly when their pain is minimized or dismissed. Moreover, there can be a tendency among healthcare providers to overlook or undervalue the symptoms reported by patients due to existing gender biases, ultimately detracting from the quality of care and the effectiveness of testing for dysmenorrhea.

Market Trends of the Global Dysmenorrhea Testing Market

The Global Dysmenorrhea Testing market is witnessing a significant upward trend driven by an increase in awareness surrounding menstrual health and the importance of early diagnosis. Government initiatives and nonprofit educational campaigns are effectively breaking the stigma associated with menstrual disorders, encouraging women to pursue dysmenorrhea testing and subsequent care. This heightened health awareness is propelling the demand for innovative testing solutions, including hormonal profiling, ultrasound diagnostics, and advanced deep learning scans that offer personalized assessments. As more women engage with healthcare providers regarding their menstrual health, the market is poised for sustained growth, reflecting a broader societal commitment to women's health and wellbeing.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Dysmenorrhea Testing Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Primary Dysmenorrhea Testing
• Secondary Dysmenorrhea Testing

Global Dysmenorrhea Testing Market Size by Type of Treatment & CAGR (2025-2032)

• Market Overview
• Market Overview
• Pain Relievers
• Hormonal Therapy
• Surgery

Global Dysmenorrhea Testing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Research Centers

Global Dysmenorrhea Testing Market Size & CAGR (2025-2032)

• North America (Product Type, Type of Treatment, End User)
  • US
  • Canada
• Europe (Product Type, Type of Treatment, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type of Treatment, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type of Treatment, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type of Treatment, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Global Pharma plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteomics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations